CPC860 (PHENAZOPYRIDINE 200 mg)
Pill imprint CPC860 has been identified as Phenazopyridine hydrochloride 200 mg.
Phenazopyridine is used in the treatment of interstitial cystitis; dysuria and belongs to the drug class miscellaneous genitourinary tract agents. There is no proven risk in humans during pregnancy. Phenazopyridine 200 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for CPC860
- 200 mg
- 19.00 mm
- Rx and/or OTC
- Drug Class:
- Miscellaneous genitourinary tract agents
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Breckenridge Pharmaceutical, Inc.
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|10267-0860||Contract Pharmacal Corporation|
|64376-0812||Boca Pharmacal Inc|
|54569-0197||A S Medication Solutions LLC (repackager)|
|21695-0301||Rebel Distributors Corp (repackager)|
|66336-0105||Dispensing Solutions Inc. (repackager)|
Note: Inactive ingredients may vary.
More about phenazopyridine
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.